{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:11:21Z","timestamp":1778253081704,"version":"3.51.4"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10338-x","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:41:37Z","timestamp":1778200897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Homeobox A10 in gastrointestinal malignancies: unraveling metastatic mechanisms and novel therapeutic opportunities"],"prefix":"10.1007","volume":"45","author":[{"given":"Sophia G.","family":"Kisling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashu","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahraa W.","family":"Alsafwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venu","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"1","key":"10338_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024). Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 74(1), 12\u201349.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"10338_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41416-024-02746-z","volume":"131","author":"J Budczies","year":"2024","unstructured":"Budczies, J., Romanovsky, E., Kirchner, M., Neumann, O., Blasi, M., Schnorbach, J., et al. (2024). KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma. British Journal of Cancer, 131(3), 524\u2013533.","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10338_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/cancers15020429","volume":"15","author":"S Nishikawa","year":"2023","unstructured":"Nishikawa, S., & Iwakuma, T. (2023). Drugs targeting p53 mutations with FDA approval and in clinical trials. Cancers, 15(2), 429.","journal-title":"Cancers"},{"issue":"11","key":"10338_CR4","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.21873\/anticanres.14622","volume":"40","author":"EN Kontomanolis","year":"2020","unstructured":"Kontomanolis, E. N., Koutras, A., Syllaios, A., Schizas, D., Mastoraki, A., Garmpis, N., et al. (2020). Role of oncogenes and tumor-suppressor genes in carcinogenesis: A review. Anticancer Research, 40(11), 6009\u20136015.","journal-title":"Anticancer Research"},{"issue":"12","key":"10338_CR5","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/ijc.33949","volume":"150","author":"R Morgan","year":"2022","unstructured":"Morgan, R., Hunter, K., & Pandha, H. S. (2022). Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer. International Journal of Cancer, 150(12), 1919\u20131932.","journal-title":"International Journal of Cancer"},{"issue":"8","key":"10338_CR6","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1093\/nar\/21.8.1687","volume":"21","author":"MP Scott","year":"1993","unstructured":"Scott, M. P. (1993). A rational nomenclature for vertebrate homeobox (HOX) genes. Nucleic Acids Research, 21(8), 1687\u20131688.","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"10338_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2174\/138920212800793375","volume":"13","author":"A Durston","year":"2012","unstructured":"Durston, A., Wacker, S., Bardine, N., & Jansen, H. (2012). Time space translation: A Hox mechanism for vertebrate A-P patterning. Current Genomics, 13(4), 300\u2013307.","journal-title":"Current Genomics"},{"issue":"1","key":"10338_CR8","first-page":"23","volume":"75","author":"TR Lappin","year":"2006","unstructured":"Lappin, T. R., Grier, D. G., Thompson, A., & Halliday, H. L. (2006). HOX genes: Seductive science, mysterious mechanisms. Ulster Medical Journal, 75(1), 23\u201331.","journal-title":"Ulster Medical Journal"},{"key":"10338_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ydbio.2021.06.002","volume":"477","author":"B De Kumar","year":"2021","unstructured":"De Kumar, B., & Darland, D. C. (2021). The Hox protein conundrum: The \u201cspecifics\u201d of DNA binding for Hox proteins and their partners. Developmental Biology, 477, 284\u201392.","journal-title":"Developmental Biology"},{"issue":"7","key":"10338_CR10","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1242\/dev.109785","volume":"142","author":"R Rezsohazy","year":"2015","unstructured":"Rezsohazy, R., Saurin, A. J., Maurel-Zaffran, C., & Graba, Y. (2015). Cellular and molecular insights into Hox protein action. Development, 142(7), 1212\u20131227.","journal-title":"Development"},{"issue":"20","key":"10338_CR11","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1073\/pnas.92.20.9166","volume":"92","author":"ST Neuteboom","year":"1995","unstructured":"Neuteboom, S. T., Peltenburg, L. T., van Dijk, M. A., & Murre, C. (1995). The hexapeptide LFPWMR in Hoxb-8 is required for cooperative DNA binding with Pbx1 and Pbx2 proteins. Proceedings of the National Academy of Sciences of the United States of America, 92(20), 9166\u201370.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10338_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1101\/gad.9.6.663","volume":"9","author":"CP Chang","year":"1995","unstructured":"Chang, C. P., Shen, W. F., Rozenfeld, S., Lawrence, H. J., Largman, C., & Cleary, M. L. (1995). Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes & Development, 9(6), 663\u201374.","journal-title":"Genes & Development"},{"issue":"6721","key":"10338_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/17833","volume":"397","author":"JM Passner","year":"1999","unstructured":"Passner, J. M., Ryoo, H. D., Shen, L., Mann, R. S., & Aggarwal, A. K. (1999). Structure of a DNA-bound Ultrabithorax-Extradenticle homeodomain complex. Nature, 397(6721), 714\u20139.","journal-title":"Nature"},{"issue":"12","key":"10338_CR14","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1093\/nar\/24.12.2288","volume":"24","author":"PS Knoepfler","year":"1996","unstructured":"Knoepfler, P. S., Lu, Q., & Kamps, M. P. (1996). Pbx-1 Hox heterodimers bind DNA on inseparable half-sites that permit intrinsic DNA binding specificity of the Hox partner at nucleotides 3\u2032 to a TAAT motif. Nucleic Acids Research, 24(12), 2288\u20132294.","journal-title":"Nucleic Acids Research"},{"issue":"7","key":"10338_CR15","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1007\/s10620-014-3033-6","volume":"59","author":"XP Cui","year":"2014","unstructured":"Cui, X. P., Qin, C. K., Zhang, Z. H., Su, Z. X., Liu, X., Wang, S. K., et al. (2014). HOXA10 promotes cell invasion and MMP-3 expression via TGF\u03b22-mediated activation of the p38 MAPK pathway in pancreatic cancer cells. Digestive Diseases and Sciences, 59(7), 1442\u20131451.","journal-title":"Digestive Diseases and Sciences"},{"issue":"6","key":"10338_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.7150\/jca.17295","volume":"8","author":"CJ Chang","year":"2017","unstructured":"Chang, C. J., Chen, Y. L., Hsieh, C. H., Liu, Y. J., Yu, S. L., Chen, J. J. W., et al. (2017). HOXA5 and p53 cooperate to suppress lung cancer cell invasion and serve as good prognostic factors in non-small cell lung cancer. Journal of Cancer, 8(6), 1071\u20131081.","journal-title":"Journal of Cancer"},{"key":"10338_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.770428","volume":"11","author":"Y Feng","year":"2021","unstructured":"Feng, Y., Zhang, T., Wang, Y., Xie, M., Ji, X., Luo, X., et al. (2021). Homeobox genes in cancers: From carcinogenesis to recent therapeutic intervention. Frontiers in Oncology, 11, Article 770428.","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"10338_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.hdy.6800847","volume":"97","author":"T Svingen","year":"2006","unstructured":"Svingen, T., & Tonissen, K. F. (2006). Hox transcription factors and their elusive mammalian gene targets. Heredity, 97(2), 88\u201396.","journal-title":"Heredity"},{"issue":"1","key":"10338_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01389-x","volume":"24","author":"US Shenoy","year":"2024","unstructured":"Shenoy, U. S., Basavarajappa, D. S., Kabekkodu, S. P., & Radhakrishnan, R. (2024). Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis. Clinical and Experimental Medicine, 24(1), Article 134.","journal-title":"Clinical and Experimental Medicine"},{"key":"10338_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0086-1","volume":"4","author":"B Xie","year":"2019","unstructured":"Xie, B., Bai, B., Xu, Y., Liu, Y., Lv, Y., Gao, X., et al. (2019). Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer. Signal Transduction and Targeted Therapy, 4, Article 51.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10338_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.biopha.2016.12.012","volume":"86","author":"H Zhang","year":"2017","unstructured":"Zhang, H., Zhao, J. H., & Suo, Z. M. (2017). Knockdown of HOXA5 inhibits the tumorigenesis in esophageal squamous cell cancer. Biomedicine & Pharmacotherapy, 86, 149\u2013154.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"9","key":"10338_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12032-025-02980-2","volume":"42","author":"J Dong","year":"2025","unstructured":"Dong, J., Gong, H., Li, J., Ma, X., Tayyab, B., & Xu, X. (2025). The role of HOXA1 in cancer and targeted therapy. Medical Oncology, 42(9), 405.","journal-title":"Medical Oncology"},{"issue":"4","key":"10338_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.70013","volume":"16","author":"Q Wang","year":"2025","unstructured":"Wang, Q., Ren, S., Pan, Z., Chen, Y., & Liu, X. (2025). HOXA5 derives the malignant progression and cisplatin resistance of esophageal squamous cell carcinoma by regulating USP18-mediated IFI27 deubiquitination. Thoracic Cancer, 16(4), Article e70013.","journal-title":"Thoracic Cancer"},{"key":"10338_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/genes15111430","author":"JV Gomes","year":"2024","unstructured":"Gomes, J. V., Nicolau-Neto, P., de Almeida, J. N., Lisboa, L. B., de Souza-Santos, P. T., Ribeiro-Pinto, L. F., et al. (2024). HOXA7 expression is an independent prognostic biomarker in esophageal squamous cell carcinoma. Genes. https:\/\/doi.org\/10.3390\/genes15111430","journal-title":"Genes"},{"key":"10338_CR25","doi-asserted-by":"publisher","first-page":"8905","DOI":"10.2147\/OTT.S227920","volume":"12","author":"C Xu","year":"2019","unstructured":"Xu, C., Li, B., Zhao, S., Jin, B., Jia, R., Ge, J., et al. (2019). MicroRNA-186-5p inhibits proliferation and metastasis of esophageal cancer by mediating HOXA9. Oncotargets and Therapy, 12, 8905\u20138914.","journal-title":"Oncotargets and Therapy"},{"issue":"1","key":"10338_CR26","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1515\/med-2022-0558","volume":"17","author":"L Jiang","year":"2022","unstructured":"Jiang, L., & Yang, Q. (2022). HOXA10 enhances cell proliferation and suppresses apoptosis in esophageal cancer via activating p38\/ERK signaling pathway. Open Medicine, 17(1), 1750\u20131759.","journal-title":"Open Medicine"},{"issue":"38","key":"10338_CR27","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1038\/onc.2017.133","volume":"36","author":"C Lin","year":"2017","unstructured":"Lin, C., Wang, Y., Wang, Y., Zhang, S., Yu, L., Guo, C., et al. (2017). Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells. Oncogene, 36(38), 5392\u20135406.","journal-title":"Oncogene"},{"key":"10338_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.552822","volume":"8","author":"W Cheng","year":"2020","unstructured":"Cheng, W., Shi, X., Lin, M., Yao, Q., Ma, J., & Li, J. (2020). LncRNA MAGI2-AS3 overexpression sensitizes esophageal cancer cells to irradiation through down-regulation of HOXB7 via EZH2. Frontiers in Cell and Developmental Biology, 8, Article 552822.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"4","key":"10338_CR29","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.3892\/ol.2017.6772","volume":"14","author":"LY Shen","year":"2017","unstructured":"Shen, L. Y., Fan, M. Y., Dong, B., Yan, W. P., & Chen, K. N. (2017). Increased HOXC6 expression predicts chemotherapy sensitivity in patients with esophageal squamous cell carcinoma. Oncology Letters, 14(4), 4835\u20134840.","journal-title":"Oncology Letters"},{"issue":"8","key":"10338_CR30","doi-asserted-by":"publisher","first-page":"13717","DOI":"10.1002\/jcb.28644","volume":"120","author":"J Zhang","year":"2019","unstructured":"Zhang, J., Liu, S., Zhang, D., Ma, Z., & Sun, L. (2019). Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma. Journal of Cellular Biochemistry, 120(8), 13717\u201325.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"6","key":"10338_CR31","first-page":"2093","volume":"52","author":"S Wu","year":"2018","unstructured":"Wu, S., Wu, F., & Jiang, Z. (2018). Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells. International Journal of Oncology, 52(6), 2093\u20132100.","journal-title":"International Journal of Oncology"},{"issue":"3","key":"10338_CR32","first-page":"2756","volume":"15","author":"Y Watanabe","year":"2018","unstructured":"Watanabe, Y., Saito, M., Saito, K., Matsumoto, Y., Kanke, Y., Onozawa, H., et al. (2018). Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer. Oncology Letters, 15(3), 2756\u20132762.","journal-title":"Oncology Letters"},{"issue":"6","key":"10338_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1089\/gtmb.2017.0240","volume":"22","author":"Y Yuan","year":"2018","unstructured":"Yuan, Y., Sun, S., Jiao, N., Shu, Y., & Zhang, Y. (2018). Upregulation of HOXA10 protein expression predicts poor prognosis for colorectal cancer. Genetic Testing and Molecular Biomarkers, 22(6), 390\u2013397.","journal-title":"Genetic Testing and Molecular Biomarkers"},{"issue":"2","key":"10338_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112238","volume":"395","author":"Y Gu","year":"2020","unstructured":"Gu, Y., Gu, J., Shen, K., Zhou, H., Hao, J., Li, F., et al. (2020). HOXA13 promotes colon cancer progression through beta-catenin-dependent WNT pathway. Experimental Cell Research, 395(2), Article 112238.","journal-title":"Experimental Cell Research"},{"key":"10338_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.803493","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang, L., Jin, H., Zeng, Y., Tan, Y., Wang, J., Fu, W., et al. (2022). HOXB4 mis-regulation induced by microcystin-LR and correlated with immune infiltration is unfavorable to colorectal cancer prognosis. Frontiers in Oncology, 12, Article 803493.","journal-title":"Frontiers in Oncology"},{"issue":"6","key":"10338_CR36","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.7150\/thno.52199","volume":"11","author":"W Feng","year":"2021","unstructured":"Feng, W., Huang, W., Chen, J., Qiao, C., Liu, D., Ji, X., et al. (2021). CXCL12-mediated HOXB5 overexpression facilitates colorectal cancer metastasis through transactivating CXCR4 and ITGB3. Theranostics., 11(6), 2612\u20132633.","journal-title":"Theranostics."},{"issue":"11","key":"10338_CR37","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1158\/1078-0432.CCR-10-2533","volume":"17","author":"WT Liao","year":"2011","unstructured":"Liao, W. T., Jiang, D., Yuan, J., Cui, Y. M., Shi, X. W., Chen, C. M., et al. (2011). HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Clinical Cancer Research, 17(11), 3569\u20133578.","journal-title":"Clinical Cancer Research"},{"key":"10338_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12935-018-0717-6","volume":"19","author":"T Wang","year":"2019","unstructured":"Wang, T., Lin, F., Sun, X., Jiang, L., Mao, R., Zhou, S., et al. (2019). HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation. Cancer Cell International, 19, 3.","journal-title":"Cancer Cell International"},{"issue":"4","key":"10338_CR39","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.3390\/ijms23042281","volume":"23","author":"E Martinou","year":"2022","unstructured":"Martinou, E., Moller-Levet, C., Karamanis, D., Bagwan, I., & Angelidi, A. M. (2022). HOXB9 overexpression promotes colorectal cancer progression and is associated with worse survival in liver resection patients for colorectal liver metastases. International journal of molecular sciences, 23(4), 2281.","journal-title":"International journal of molecular sciences"},{"issue":"11","key":"10338_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21346","volume":"9","author":"S Wu","year":"2023","unstructured":"Wu, S., Zhu, D., Feng, H., Li, Y., Zhou, J., Li, Y., et al. (2023). Comprehensive analysis of HOXC8 associated with tumor microenvironment characteristics in colorectal cancer. Heliyon., 9(11), Article e21346.","journal-title":"Heliyon."},{"key":"10338_CR41","doi-asserted-by":"crossref","unstructured":"Hu, M., Ou-Yang, W., Jing, D., & Chen, R. (2019). Clinical prognostic significance of HOXC9 expression in patients with colorectal cancer. Clinical Laboratory, 65(8).","DOI":"10.7754\/Clin.Lab.2019.190122"},{"issue":"12","key":"10338_CR42","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.7150\/jca.76945","volume":"13","author":"J Yu","year":"2022","unstructured":"Yu, J., Chen, X., Zhao, S., Jing, J., Wang, Q., & Dang, Y. (2022). HOXC10 promotes metastasis in colorectal cancer by recruiting myeloid-derived suppressor cells. Journal of Cancer, 13(12), 3308\u201317.","journal-title":"Journal of Cancer"},{"issue":"6","key":"10338_CR43","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2015.11.001","volume":"28","author":"P Ordonez-Moran","year":"2015","unstructured":"Ordonez-Moran, P., Dafflon, C., Imajo, M., Nishida, E., & Huelsken, J. (2015). HOXA5 counteracts stem cell traits by inhibiting Wnt signaling in colorectal cancer. Cancer Cell, 28(6), 815\u2013829.","journal-title":"Cancer Cell"},{"issue":"12","key":"10338_CR44","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/sj.bjc.6602631","volume":"92","author":"C Jung","year":"2005","unstructured":"Jung, C., Kim, R. S., Zhang, H., Lee, S. J., Sheng, H., Loehrer, P. J., et al. (2005). HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. British Journal of Cancer, 92(12), 2233\u20132239.","journal-title":"British Journal of Cancer"},{"key":"10338_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2017.04.011","volume":"88","author":"MA Mansour","year":"2017","unstructured":"Mansour, M. A., & Senga, T. (2017). HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer. International Journal of Biochemistry & Cell Biology, 88, 1\u201313.","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"1","key":"10338_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12964-018-0316-0","volume":"17","author":"YH Yuan","year":"2019","unstructured":"Yuan, Y. H., Wang, H. Y., Lai, Y., Zhong, W., Liang, W. L., Yan, F. D., et al. (2019). Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC\/AKT\/MAPK signaling pathway. Cell Communication and Signaling: CCS, 17(1), 9.","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10338_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-016-0294-2","volume":"35","author":"C Yuan","year":"2016","unstructured":"Yuan, C., Zhu, X., Han, Y., Song, C., Liu, C., Lu, S., et al. (2016). Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1. Journal of Experimental & Clinical Cancer Research, 35, 15.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"5","key":"10338_CR48","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.18632\/aging.202426","volume":"13","author":"J Lin","year":"2021","unstructured":"Lin, J., Zhu, H., Hong, L., Tang, W., Wang, J., Hu, H., et al. (2021). Co-expression of HOXA6 and PBX2 promotes metastasis in gastric cancer. Aging (Albany NY), 13(5), 6606\u201324.","journal-title":"Aging (Albany NY)"},{"key":"10338_CR49","doi-asserted-by":"crossref","unstructured":"Li, Z., Lu, T., Chen, Z., Yu, X., Wang, L., Shen, G., & Hu, Y. (2023). HOXA11 promotes lymphatic metastasis of gastric cancer via transcriptional activation of TGF\u03b21. iScience, 26(8), 107346.","DOI":"10.1016\/j.isci.2023.107346"},{"issue":"6","key":"10338_CR50","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/mc.22793","volume":"57","author":"Y Han","year":"2018","unstructured":"Han, Y., Song, C., Wang, J., Tang, H., Peng, Z., & Lu, S. (2018). HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway. Molecular Carcinogenesis, 57(6), 722\u2013734.","journal-title":"Molecular Carcinogenesis"},{"issue":"3","key":"10338_CR51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20150213","volume":"472","author":"CS Hong","year":"2015","unstructured":"Hong, C. S., Jeong, O., Piao, Z., Guo, C., Jung, M. R., Choi, C., et al. (2015). HOXB5 induces invasion and migration through direct transcriptional up-regulation of beta-catenin in human gastric carcinoma. The Biochemical Journal, 472(3), 393\u2013403.","journal-title":"The Biochemical Journal"},{"issue":"1","key":"10338_CR52","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.18632\/oncotarget.13604","volume":"8","author":"X He","year":"2017","unstructured":"He, X., Liu, Z., Xia, Y., Xu, J., Lv, G., Wang, L., et al. (2017). HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs. Oncotarget, 8(1), 1247\u20131261.","journal-title":"Oncotarget"},{"issue":"3","key":"10338_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00432-016-2283-4","volume":"143","author":"WJ Ding","year":"2017","unstructured":"Ding, W. J., Zhou, M., Chen, M. M., & Qu, C. Y. (2017). HOXB8 promotes tumor metastasis and the epithelial-mesenchymal transition via ZEB2 targets in gastric cancer. Journal of Cancer Research and Clinical Oncology, 143(3), 385\u201397.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"8","key":"10338_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236811","volume":"15","author":"J Jung","year":"2020","unstructured":"Jung, J., Jeong, S., Jeong, H., Oh, H. E., Choi, J. W., Lee, E. S., et al. (2020). Increased HOXC6 mRNA expression is a novel biomarker of gastric cancer. PLoS ONE, 15(8), Article e0236811.","journal-title":"PLoS ONE"},{"issue":"12","key":"10338_CR55","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1007\/s10147-020-01772-0","volume":"25","author":"XF Zhao","year":"2020","unstructured":"Zhao, X. F., Yang, Y. S., & Park, Y. K. (2020). HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients. International Journal of Clinical Oncology, 25(12), 2044\u20132054.","journal-title":"International Journal of Clinical Oncology"},{"issue":"1","key":"10338_CR56","first-page":"202","volume":"42","author":"J Kim","year":"2019","unstructured":"Kim, J., Bae, D. H., Kim, J. H., Song, K. S., Kim, Y. S., & Kim, S. Y. (2019). HOXC10 overexpression promotes cell proliferation and migration in gastric cancer. Oncology Reports, 42(1), 202\u2013212.","journal-title":"Oncology Reports"},{"issue":"1","key":"10338_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/sjg.SJG_105_18","volume":"25","author":"H Liu","year":"2019","unstructured":"Liu, H., Tian, H., Zhao, J., & Jia, Y. (2019). High HOXD4 protein expression in gastric adenocarcinoma tissues indicates unfavorable clinical outcomes. Saudi Journal of Gastroenterology, 25(1), 46\u201354.","journal-title":"Saudi Journal of Gastroenterology"},{"issue":"1","key":"10338_CR58","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s13046-019-1399-1","volume":"38","author":"H Zhu","year":"2019","unstructured":"Zhu, H., Dai, W., Li, J., Xiang, L., Wu, X., Tang, W., et al. (2019). HOXD9 promotes the growth, invasion and metastasis of gastric cancer cells by transcriptional activation of RUFY3. Journal of Experimental & Clinical Cancer Research, 38(1), 412.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"3","key":"10338_CR59","first-page":"1317","volume":"40","author":"X Peng","year":"2018","unstructured":"Peng, X., Zha, L., Chen, A., & Wang, Z. (2018). HOXA5 is a tumor suppressor gene that is decreased in gastric cancer. Oncology Reports, 40(3), 1317\u20131329.","journal-title":"Oncology Reports"},{"issue":"40","key":"10338_CR60","doi-asserted-by":"publisher","first-page":"42838","DOI":"10.18632\/oncotarget.5814","volume":"6","author":"Q Chang","year":"2015","unstructured":"Chang, Q., Zhang, L., He, C., Zhang, B., Zhang, J., Liu, B., et al. (2015). HOXB9 induction of mesenchymal-to-epithelial transition in gastric carcinoma is negatively regulated by its hexapeptide motif. Oncotarget, 6(40), 42838\u201342853.","journal-title":"Oncotarget"},{"issue":"9","key":"10338_CR61","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00432-024-05950-9","volume":"150","author":"G Bao","year":"2024","unstructured":"Bao, G., Wei, H., Yan, J., Li, Y., Xue, C., Fu, R., et al. (2024). HOXA9 promotes proliferation, metastasis and prevents apoptosis in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 150(9), 422.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10338_CR62","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.2147\/CMAR.S199239","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y., Chen, J., Wu, S. S., Lv, M. J., Yu, Y. S., Tang, Z. H., et al. (2019). HOXA10 knockdown inhibits proliferation, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells through HDAC1. Cancer Manag Res., 11, 7065\u20137076.","journal-title":"Cancer Manag Res."},{"issue":"1","key":"10338_CR63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/labinvest.2017.107","volume":"98","author":"L Quagliata","year":"2018","unstructured":"Quagliata, L., Quintavalle, C., Lanzafame, M., Matter, M. S., Novello, C., di Tommaso, L., et al. (2018). High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models. Laboratory Investigation, 98(1), 95\u2013105.","journal-title":"Laboratory Investigation"},{"issue":"6","key":"10338_CR64","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/1440-1681.13278","volume":"47","author":"B Su","year":"2020","unstructured":"Su, B., Zhang, X., & Luo, G. (2020). Homeobox B5 suppression attenuates proliferation and elevates apoptosis in hepatoma cell lines through ERK\/MDM2 signalling. Clinical and Experimental Pharmacology & Physiology, 47(6), 1058\u20131066.","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"29","key":"10338_CR65","doi-asserted-by":"publisher","first-page":"47121","DOI":"10.18632\/oncotarget.17004","volume":"8","author":"WM Wang","year":"2017","unstructured":"Wang, W. M., Xu, Y., Wang, Y. H., Sun, H. X., Sun, Y. F., He, Y. F., et al. (2017). HOXB7 promotes tumor progression via bFGF-induced activation of MAPK\/ERK pathway and indicated poor prognosis in hepatocellular carcinoma. Oncotarget, 8(29), 47121\u201335.","journal-title":"Oncotarget"},{"issue":"1","key":"10338_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10238-014-0276-7","volume":"15","author":"L Sha","year":"2015","unstructured":"Sha, L., Dong, L., Lv, L., Bai, L., & Ji, X. (2015). HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-beta1 pathway in hepatocellular carcinoma cells. Clinical and Experimental Medicine, 15(1), 55\u201364.","journal-title":"Clinical and Experimental Medicine"},{"issue":"1","key":"10338_CR67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.18632\/aging.101363","volume":"10","author":"PD Li","year":"2018","unstructured":"Li, P. D., Chen, P., Peng, X., Ma, C., Zhang, W. J., & Dai, X. F. (2018). HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition. Aging (Albany NY), 10(1), 115\u201330.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10338_CR68","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12672-023-00786-0","volume":"14","author":"M Li","year":"2023","unstructured":"Li, M., Guo, Q., Shi, Q., Rao, Y., Dong, Y., Chen, F., et al. (2023). M(6)A-mediated upregulation of HOXC10 promotes human hepatocellular carcinoma development through PTEN\/AKT\/mTOR signaling pathway. Discov Oncol., 14(1), 175.","journal-title":"Discov Oncol."},{"issue":"3","key":"10338_CR69","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41419-024-06593-x","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang, L., Qiao, C., Han, L., Wang, X., Miao, J., Cao, L., et al. (2024). HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20. Cell Death & Disease, 15(3), 221.","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10338_CR70","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13062-025-00620-3","volume":"20","author":"E Guo","year":"2025","unstructured":"Guo, E., Li, L., Yang, J., Zhou, Y., Bai, L., Zhu, W., et al. (2025). HOXB4\/METTL7B cascade mediates malignant phenotypes of hepatocellular carcinoma through TKT m6A modification. Biology Direct, 20(1), 26.","journal-title":"Biology Direct"},{"key":"10338_CR71","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13148-017-0412-9","volume":"9","author":"Y Guo","year":"2017","unstructured":"Guo, Y., Peng, Y., Gao, D., Zhang, M., Yang, W., Linghu, E., et al. (2017). Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma. Clinical Epigenetics, 9, 116.","journal-title":"Clinical Epigenetics"},{"key":"10338_CR72","doi-asserted-by":"crossref","unstructured":"Kuo, T. L., Cheng, K. H., Chen, L. T., & Hung, W. C. (2019). Deciphering the potential role of HOX genes in pancreatic cancer. Cancers, 11(5).","DOI":"10.3390\/cancers11050734"},{"key":"10338_CR73","doi-asserted-by":"crossref","unstructured":"Fu, Z., Chen, C., Zhou, Q., Wang, Y., Zhao, Y., Zhao, X., & Chen, R. (2022). Corrigendum to \"LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9\"[Canc. Lett. 410 (2017) 68-81]. Cancer letters, 545,\u00a0215836.","DOI":"10.1016\/j.canlet.2022.215836"},{"issue":"8","key":"10338_CR74","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/carcin\/bgac042","volume":"43","author":"J Li","year":"2022","unstructured":"Li, J., Chang, J., Wang, J., Xu, D., Yang, M., Jiang, Y., et al. (2022). HOXA10 promote pancreatic cancer progression via directly activating canonical NF-kappaB signaling pathway. Carcinogenesis, 43(8), 787\u2013796.","journal-title":"Carcinogenesis"},{"issue":"2","key":"10338_CR75","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/15384101.2019.1707456","volume":"19","author":"ZX Li","year":"2020","unstructured":"Li, Z. X., Wu, G., Jiang, W. J., Li, J., Wang, Y. Y., Ju, X. M., et al. (2020). HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway. Cell Cycle, 19(2), 233\u2013245.","journal-title":"Cell Cycle"},{"issue":"3","key":"10338_CR76","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/cncr.27725","volume":"119","author":"A Nguyen Kovochich","year":"2013","unstructured":"Nguyen Kovochich, A., Arensman, M., Lay, A. R., Rao, N. P., Donahue, T., Li, X., et al. (2013). HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma. Cancer, 119(3), 529\u2013539.","journal-title":"Cancer"},{"issue":"13","key":"10338_CR77","doi-asserted-by":"publisher","first-page":"11103","DOI":"10.18632\/aging.206008","volume":"16","author":"H Zhang","year":"2024","unstructured":"Zhang, H., Han, B., Tian, S., Gong, Y., Chen, L., & Liu, L. (2024). HOXC4 promotes proliferation of pancreatic cancer cells by increasing LDHA-mediated glycolysis. Aging (Albany NY), 16(13), 11103\u201316.","journal-title":"Aging (Albany NY)"},{"key":"10338_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215595","volume":"533","author":"Y Yao","year":"2022","unstructured":"Yao, Y., Liu, C., Wang, B., Guan, X., Fang, L., Zhan, F., et al. (2022). HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1\/RBL2\/c-Myc axis. Cancer Letters, 533, Article 215595.","journal-title":"Cancer Letters"},{"issue":"2","key":"10338_CR79","doi-asserted-by":"publisher","first-page":"385","DOI":"10.21037\/gs.2020.03.28","volume":"9","author":"Z Lin","year":"2020","unstructured":"Lin, Z., Hu, Y., Lin, R., & Ye, H. (2020). The effect of overexpression of the HOXD10 gene on the malignant proliferation, invasion, and tumor formation of pancreatic cancer cell PANC-1. Gland Surgery, 9(2), 385\u2013391.","journal-title":"Gland Surgery"},{"issue":"15","key":"10338_CR80","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1242\/dev.081448","volume":"139","author":"I Guerreiro","year":"2012","unstructured":"Guerreiro, I., Casaca, A., Nunes, A., Monteiro, S., Novoa, A., Ferreira, R. B., et al. (2012). Regulatory role for a conserved motif adjacent to the homeodomain of Hox10 proteins. Development, 139(15), 2703\u20132710.","journal-title":"Development"},{"issue":"12","key":"10338_CR81","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1111\/febs.14476","volume":"285","author":"S Li","year":"2018","unstructured":"Li, S., Zhang, W., Wu, C., Gao, H., Yu, J., Wang, X., et al. (2018). HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma. The FEBS Journal, 285(12), 2278\u20132291.","journal-title":"The FEBS Journal"},{"issue":"22","key":"10338_CR82","doi-asserted-by":"publisher","first-page":"18230","DOI":"10.1074\/jbc.M111.328401","volume":"287","author":"CA Shah","year":"2012","unstructured":"Shah, C. A., Bei, L., Wang, H., Platanias, L. C., & Eklund, E. A. (2012). HoxA10 protein regulates transcription of gene encoding fibroblast growth factor 2 (FGF2) in myeloid cells. The Journal of Biological Chemistry, 287(22), 18230\u201318248.","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10338_CR83","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1741-4520.2003.00004.x","volume":"44","author":"N Yahagi","year":"2004","unstructured":"Yahagi, N., Kosaki, R., Ito, T., Mitsuhashi, T., Shimada, H., Tomita, M., et al. (2004). Position-specific expression of Hox genes along the gastrointestinal tract. Congenit Anom (Kyoto)., 44(1), 18\u201326.","journal-title":"Congenit Anom (Kyoto)."},{"issue":"1","key":"10338_CR84","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11154-024-09923-8","volume":"26","author":"A Mishra","year":"2025","unstructured":"Mishra, A., & Modi, D. (2025). Role of HOXA10 in pathologies of the endometrium. Reviews in Endocrine & Metabolic Disorders, 26(1), 81\u201396.","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"issue":"2","key":"10338_CR85","doi-asserted-by":"publisher","first-page":"70","DOI":"10.21037\/atm-21-6589","volume":"10","author":"P Wen","year":"2022","unstructured":"Wen, P., Dayyani, F., Tao, R., & Zhong, X. (2022). Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry. Annals of Translational Medicine, 10(2), 70.","journal-title":"Annals of Translational Medicine"},{"issue":"3","key":"10338_CR86","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/15384101.2022.2108633","volume":"22","author":"J Kuai","year":"2023","unstructured":"Kuai, J., Wu, K., Han, T., Zhai, W., & Sun, R. (2023). LncRNA HOXA10-AS promotes the progression of esophageal carcinoma by regulating the expression of HOXA10. Cell Cycle, 22(3), 276\u2013290.","journal-title":"Cell Cycle"},{"issue":"41","key":"10338_CR87","doi-asserted-by":"publisher","first-page":"7078","DOI":"10.3748\/wjg.v19.i41.7078","volume":"19","author":"JY Lim","year":"2013","unstructured":"Lim, J. Y., Yoon, S. O., Seol, S. Y., Hong, S. W., Kim, J. W., Choi, S. H., et al. (2013). Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. World Journal of Gastroenterology, 19(41), 7078\u20137088.","journal-title":"World Journal of Gastroenterology"},{"issue":"12","key":"10338_CR88","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ejcb.2015.08.004","volume":"94","author":"Y Han","year":"2015","unstructured":"Han, Y., Lu, S., Wen, Y. G., Yu, F. D., Zhu, X. W., Qiu, G. Q., et al. (2015). Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)\/CD44(+) is potential prognostic biomarker for gastric cancer. European Journal of Cell Biology, 94(12), 642\u2013652.","journal-title":"European Journal of Cell Biology"},{"issue":"5","key":"10338_CR89","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/carcin\/bgs121","volume":"33","author":"K Sentani","year":"2012","unstructured":"Sentani, K., Oue, N., Naito, Y., Sakamoto, N., Anami, K., Oo, H. Z., et al. (2012). Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: Reduction during tumor progression and favorable prognosis. Carcinogenesis, 33(5), 1081\u20131088.","journal-title":"Carcinogenesis"},{"issue":"1","key":"10338_CR90","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13046-021-01859-0","volume":"40","author":"C Song","year":"2021","unstructured":"Song, C., & Zhou, C. (2021). HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2\/Smad\/METTL3 signaling axis. Journal of Experimental & Clinical Cancer Research, 40(1), 62.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"12","key":"10338_CR91","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1002\/cam4.2440","volume":"8","author":"C Song","year":"2019","unstructured":"Song, C., Han, Y., Luo, H., Qin, Z., Chen, Z., Liu, Y., et al. (2019). HOXA10 induces BCL2 expression, inhibits apoptosis, and promotes cell proliferation in gastric cancer. Cancer Medicine, 8(12), 5651\u201361.","journal-title":"Cancer Medicine"},{"key":"10338_CR92","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.2147\/CMAR.S201342","volume":"11","author":"W Chen","year":"2019","unstructured":"Chen, W., Wu, G., Zhu, Y., Zhang, W., Zhang, H., Zhou, Y., et al. (2019). HOXA10 deteriorates gastric cancer through activating JAK1\/STAT3 signaling pathway. Cancer Manag Res., 11, 6625\u20136635.","journal-title":"Cancer Manag Res."},{"issue":"5","key":"10338_CR93","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3892\/ijo.2014.2310","volume":"44","author":"RY Liu","year":"2014","unstructured":"Liu, R. Y., Zeng, Y., Lei, Z., Wang, L., Yang, H., Liu, Z., et al. (2014). JAK\/STAT3 signaling is required for TGF-beta-induced epithelial-mesenchymal transition in lung cancer cells. International Journal of Oncology, 44(5), 1643\u20131651.","journal-title":"International Journal of Oncology"},{"key":"10338_CR94","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.biopha.2017.12.035","volume":"98","author":"B Wang","year":"2018","unstructured":"Wang, B., Liu, T., Wu, J. C., Luo, S. Z., Chen, R., Lu, L. G., et al. (2018). STAT3 aggravates TGF-beta1-induced hepatic epithelial-to-mesenchymal transition and migration. Biomedicine & Pharmacotherapy, 98, 214\u2013221.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"5","key":"10338_CR95","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12282-019-00966-3","volume":"26","author":"X Gao","year":"2019","unstructured":"Gao, X., Liu, X., Lu, Y., Wang, Y., Cao, W., Liu, X., et al. (2019). PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation. Breast Cancer, 26(5), 663\u2013671.","journal-title":"Breast Cancer"},{"issue":"3","key":"10338_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70187","volume":"39","author":"Y Hu","year":"2025","unstructured":"Hu, Y., Zhang, Y., Ding, M., & Xu, R. (2025). HOXA10-AS enhances gastric cancer cell proliferation, migration, and invasion via the p38 MAPK\/STAT3 signaling pathway. Journal of Biochemical and Molecular Toxicology, 39(3), Article e70187.","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"issue":"3\u20134","key":"10338_CR97","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1159\/000452570","volume":"40","author":"M Fang","year":"2016","unstructured":"Fang, M., Wu, J., Lai, X., Ai, H., Tao, Y., Zhu, B., et al. (2016). CD44 and CD44v6 are correlated with gastric cancer progression and poor patient prognosis: Evidence from 42 studies. Cellular Physiology and Biochemistry, 40(3\u20134), 567\u2013578.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"1","key":"10338_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-021-02229-y","volume":"19","author":"YQ Li","year":"2021","unstructured":"Li, Y. Q., Zheng, Z., Liu, Q. X., Lu, X., Zhou, D., Zhang, J., et al. (2021). Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration. World Journal of Surgical Oncology, 19(1), Article 109.","journal-title":"World Journal of Surgical Oncology"},{"key":"10338_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111765","author":"L Salvatore","year":"2019","unstructured":"Salvatore, L., Calegari, M. A., Loupakis, F., Fassan, M., Di Stefano, B., Bensi, M., et al. (2019). PTEN in colorectal cancer: Shedding light on its role as predictor and target. Cancers. https:\/\/doi.org\/10.3390\/cancers11111765","journal-title":"Cancers"},{"issue":"12","key":"10338_CR100","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/s41416-020-0834-6","volume":"122","author":"T Vidotto","year":"2020","unstructured":"Vidotto, T., Melo, C. M., Castelli, E., Koti, M., Dos Reis, R. B., & Squire, J. A. (2020). Emerging role of PTEN loss in evasion of the immune response to tumours. British Journal of Cancer, 122(12), 1732\u201343.","journal-title":"British Journal of Cancer"},{"issue":"7","key":"10338_CR101","first-page":"4039","volume":"7","author":"ZD Xiao","year":"2014","unstructured":"Xiao, Z. D., Jiao, C. Y., Huang, H. T., He, L. J., Zhao, J. J., Lu, Z. Y., et al. (2014). miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN\/AKT\/PI3K pathway and HoxA10. International Journal of Clinical and Experimental Pathology, 7(7), 4039\u20134044.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"5-6","key":"10338_CR102","doi-asserted-by":"publisher","first-page":"165","DOI":"10.18632\/genesandcancer.16","volume":"5","author":"JW Kim","year":"2014","unstructured":"Kim, J. W., Kim, J. Y., Kim, J. E., Kim, S. K., Chung, H. T., & Park, C. K. (2014). HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines. Genes & Cancer, 5(5\u20136), 165\u201374.","journal-title":"Genes & Cancer"},{"key":"10338_CR103","doi-asserted-by":"crossref","unstructured":"Zhu, H., Li, Y., Zhang, Y., Zhang, Z., Wang, Y., He, G., & Hu, Y. (2020). LincHOXA10 facilitates colorectal cancer development by regulating HOXA10-mediated epithelial-mesenchymal transtion,15 June 2020.","DOI":"10.21203\/rs.3.rs-34200\/v1"},{"key":"10338_CR104","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20191087","author":"X Yang","year":"2019","unstructured":"Yang, X., Chen, J., Liao, Y., Huang, L., Wen, C., Lin, M., et al. (2019). MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10. Bioscience Reports. https:\/\/doi.org\/10.1042\/BSR20191087","journal-title":"Bioscience Reports"},{"issue":"9","key":"10338_CR105","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s10620-016-4186-2","volume":"61","author":"S Sun","year":"2016","unstructured":"Sun, S., Su, C., Zhu, Y., Li, H., Liu, N., Xu, T., et al. (2016). MicroRNA-544a regulates migration and invasion in colorectal cancer cells via regulation of Homeobox A10. Digestive Diseases and Sciences, 61(9), 2535\u201344.","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10338_CR106","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1530\/REP-08-0376","volume":"139","author":"H Du","year":"2010","unstructured":"Du, H., Vitiello, D., Sarno, J. L., & Taylor, H. S. (2010). 3-Phosphoglycerate dehydrogenase expression is regulated by HOXA10 in murine endometrium and human endometrial cells. Reproduction (Cambridge, England), 139(1), 237\u2013245.","journal-title":"Reproduction (Cambridge, England)"},{"key":"10338_CR107","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146187","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Yu, H., Zhang, J., Gao, H., Wang, S., Li, S., et al. (2021). Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine. Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI146187","journal-title":"Journal of Clinical Investigation"},{"issue":"7831","key":"10338_CR108","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41586-020-2609-x","volume":"586","author":"T Muthusamy","year":"2020","unstructured":"Muthusamy, T., Cordes, T., Handzlik, M. K., You, L., Lim, E. W., Gengatharan, J., et al. (2020). Serine restriction alters sphingolipid diversity to constrain tumour growth. Nature, 586(7831), 790\u20135.","journal-title":"Nature"},{"issue":"1","key":"10338_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0921-y","volume":"17","author":"M Shao","year":"2018","unstructured":"Shao, M., Yang, Q., Zhu, W., Jin, H., Wang, J., Song, J., et al. (2018). LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation. Molecular Cancer, 17(1), Article 173.","journal-title":"Molecular Cancer"},{"issue":"1","key":"10338_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0602-2","volume":"16","author":"K Qureshi-Baig","year":"2017","unstructured":"Qureshi-Baig, K., Ullmann, P., Haan, S., & Letellier, E. (2017). Tumor-initiating cells: A criTICal review of isolation approaches and new challenges in targeting strategies. Molecular Cancer, 16(1), Article 40.","journal-title":"Molecular Cancer"},{"issue":"8","key":"10338_CR111","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw, P. E., Liu, Q., Wong, P. P., & Song, E. (2024). Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell, 31(8), 1101\u20131112.","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10338_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109674","volume":"36","author":"X He","year":"2021","unstructured":"He, X., Smith, S. E., Chen, S., Li, H., Wu, D., Meneses-Giles, P. I., et al. (2021). Tumor-initiating stem cell shapes its microenvironment into an immunosuppressive barrier and pro-tumorigenic niche. Cell Reports, 36(10), Article 109674.","journal-title":"Cell Reports"},{"issue":"12","key":"10338_CR113","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.ccell.2024.10.008","volume":"42","author":"C Yang","year":"2024","unstructured":"Yang, C., Geng, H., Yang, X., Ji, S., Liu, Z., Feng, H., et al. (2024). Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy. Cancer Cell, 42(12), 2064\u201381 e19.","journal-title":"Cancer Cell"},{"issue":"5","key":"10338_CR114","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2019.03.025","volume":"177","author":"Y Miao","year":"2019","unstructured":"Miao, Y., Yang, H., Levorse, J., Yuan, S., Polak, L., Sribour, M., et al. (2019). Adaptive immune resistance emerges from tumor-initiating stem cells. Cell, 177(5), 1172\u201386 e14.","journal-title":"Cell"},{"key":"10338_CR115","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay1813","author":"S Taniguchi","year":"2020","unstructured":"Taniguchi, S., Elhance, A., Van Duzer, A., Kumar, S., Leitenberger, J. J., & Oshimori, N. (2020). Tumor-initiating cells establish an IL-33-TGF-beta niche signaling loop to promote cancer progression. Science. https:\/\/doi.org\/10.1126\/science.aay1813","journal-title":"Science"},{"issue":"12","key":"10338_CR116","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri.2016.99","volume":"16","author":"C Munoz-Fontela","year":"2016","unstructured":"Munoz-Fontela, C., Mandinova, A., Aaronson, S. A., & Lee, S. W. (2016). Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nature Reviews. Immunology, 16(12), 741\u2013750.","journal-title":"Nature Reviews. Immunology"},{"issue":"7","key":"10338_CR117","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/cdd.2014.212","volume":"22","author":"L Li","year":"2015","unstructured":"Li, L., Ng, D. S., Mah, W. C., Almeida, F. F., Rahmat, S. A., Rao, V. K., et al. (2015). A unique role for p53 in the regulation of M2 macrophage polarization. Cell Death and Differentiation, 22(7), 1081\u20131093.","journal-title":"Cell Death and Differentiation"},{"key":"10338_CR118","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01607-18","author":"Q Yang","year":"2019","unstructured":"Yang, Q., Zhang, Q., Zhang, X., You, L., Wang, W., Liu, W., et al. (2019). HoxA10 facilitates SHP-1-catalyzed dephosphorylation of p38 MAPK\/STAT3 to repress hepatitis B virus replication by a feedback regulatory mechanism. Journal of Virology. https:\/\/doi.org\/10.1128\/JVI.01607-18","journal-title":"Journal of Virology"},{"key":"10338_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-020-00428-w","volume":"10","author":"M Jiang","year":"2020","unstructured":"Jiang, M., Ye, J., Wang, X., Li, N., Wang, Y., & Shi, Y. (2020). Phosphatase SHP1 impedes mesenchymal stromal cell immunosuppressive capacity modulated by JAK1\/STAT3 and P38 signals. Cell & Bioscience, 10, Article 65.","journal-title":"Cell & Bioscience"},{"issue":"1","key":"10338_CR120","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s11658-023-00438-9","volume":"28","author":"M Hashemi","year":"2023","unstructured":"Hashemi, M., Sabouni, E., Rahmanian, P., Entezari, M., Mojtabavi, M., Raei, B., et al. (2023). Deciphering STAT3 signaling potential in hepatocellular carcinoma: Tumorigenesis, treatment resistance, and pharmacological significance. Cellular & Molecular Biology Letters, 28(1), 33.","journal-title":"Cellular & Molecular Biology Letters"},{"issue":"7753","key":"10338_CR121","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41586-019-1112-8","volume":"568","author":"A Tomas-Loba","year":"2019","unstructured":"Tomas-Loba, A., Manieri, E., Gonzalez-Teran, B., Mora, A., Leiva-Vega, L., Santamans, A. M., et al. (2019). p38gamma is essential for cell cycle progression and liver tumorigenesis. Nature, 568(7753), 557\u2013560.","journal-title":"Nature"},{"issue":"9","key":"10338_CR122","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41417-023-00622-1","volume":"30","author":"T Phan","year":"2023","unstructured":"Phan, T., Zhang, X. H., Rosen, S., & Melstrom, L. G. (2023). P38 kinase in gastrointestinal cancers. Cancer Gene Therapy, 30(9), 1181\u20131189.","journal-title":"Cancer Gene Therapy"},{"issue":"16","key":"10338_CR123","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1158\/0008-5472.CAN-17-3896","volume":"78","author":"LZ Wen","year":"2018","unstructured":"Wen, L. Z., Ding, K., Wang, Z. R., Ding, C. H., Lei, S. J., Liu, J. P., et al. (2018). SHP-1 acts as a tumor suppressor in hepatocarcinogenesis and HCC progression. Cancer Research, 78(16), 4680\u20134691.","journal-title":"Cancer Research"},{"issue":"18","key":"10338_CR124","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1158\/1078-0432.CCR-23-0825","volume":"29","author":"SG Kisling","year":"2023","unstructured":"Kisling, S. G., Atri, P., Shah, A., Cox, J. L., Sharma, S., Smith, L. M., et al. (2023). A novel HOXA10-associated 5-gene-based prognostic signature for stratification of short-term survivors of pancreatic ductal adenocarcinoma. Clinical Cancer Research, 29(18), 3759\u20133770.","journal-title":"Clinical Cancer Research"},{"issue":"9","key":"10338_CR125","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.7150\/ijbs.70546","volume":"18","author":"W Wu","year":"2022","unstructured":"Wu, W., Li, Q., Zhu, Z., Li, C., Lu, P., Zhou, X., et al. (2022). HTR1D functions as a key target of HOXA10-AS\/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway. International Journal of Biological Sciences, 18(9), 3777\u20133794.","journal-title":"International Journal of Biological Sciences"},{"issue":"8","key":"10338_CR126","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/0008-5472.CAN-23-1200","volume":"84","author":"SP Singh","year":"2024","unstructured":"Singh, S. P., Dosch, A. R., Mehra, S., De Castro, S. I., Bianchi, A., Garrido, V. T., et al. (2024). Tumor cell-intrinsic p38 MAPK signaling promotes IL1alpha-mediated stromal inflammation and therapeutic resistance in pancreatic cancer. Cancer Research, 84(8), 1320\u20131332.","journal-title":"Cancer Research"},{"issue":"32","key":"10338_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401492","volume":"11","author":"M Zhong","year":"2024","unstructured":"Zhong, M., Xu, W., Tian, P., Zhang, Q., Wang, Z., Liang, L., et al. (2024). An inherited allele confers prostate cancer progression and drug resistance via RFX6\/HOXA10-orchestrated TGFbeta signaling. Adv Sci (Weinh)., 11(32), Article e2401492.","journal-title":"Adv Sci (Weinh)."},{"issue":"1","key":"10338_CR128","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13046-021-01867-0","volume":"40","author":"T Ma","year":"2021","unstructured":"Ma, T., Yan, B., Hu, Y., & Zhang, Q. (2021). HOXA10 promotion of HDAC1 underpins the development of lung adenocarcinoma through the DNMT1-KLF4 axis. Journal of Experimental & Clinical Cancer Research\u202f: CR, 40(1), 71.","journal-title":"Journal of Experimental & Clinical Cancer Research : CR"},{"issue":"1","key":"10338_CR129","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1186\/s12885-021-08465-5","volume":"21","author":"T Huang","year":"2021","unstructured":"Huang, T., Chen, Y., Zeng, Y., Xu, C., Huang, J., Hu, W., et al. (2021). Long noncoding RNA PSMA3-AS1 promotes glioma progression through modulating the miR-411-3p\/HOXA10 pathway. BMC Cancer, 21(1), 844.","journal-title":"BMC Cancer"},{"issue":"1","key":"10338_CR130","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13046-021-02088-1","volume":"40","author":"S Nie","year":"2021","unstructured":"Nie, S., Zhang, L., Liu, J., Wan, Y., Jiang, Y., Yang, J., et al. (2021). ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. Journal of Experimental & Clinical Cancer Research, 40(1), 284.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10338_CR131","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13148-017-0373-z","volume":"9","author":"SM Park","year":"2017","unstructured":"Park, S. M., Choi, E. Y., Bae, M., Choi, J. K., & Kim, Y. J. (2017). A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients. Clinical Epigenetics, 9, 73.","journal-title":"Clinical Epigenetics"},{"issue":"4","key":"10338_CR132","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1210\/me.2002-0290","volume":"17","author":"MW Yao","year":"2003","unstructured":"Yao, M. W., Lim, H., Schust, D. J., Choe, S. E., Farago, A., Ding, Y., et al. (2003). Gene expression profiling reveals progesterone-mediated cell cycle and immunoregulatory roles of Hoxa-10 in the preimplantation uterus. Molecular Endocrinology, 17(4), 610\u2013627.","journal-title":"Molecular Endocrinology"},{"issue":"16","key":"10338_CR133","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3748\/wjg.v30.i16.2195","volume":"30","author":"XJ Zhang","year":"2024","unstructured":"Zhang, X. J., Yu, Y., Zhao, H. P., Guo, L., Dai, K., & Lv, J. (2024). Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer. World Journal of Gastroenterology, 30(16), 2195\u20132208.","journal-title":"World Journal of Gastroenterology"},{"issue":"7","key":"10338_CR134","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda, T., & Wang, Y. A. (2024). Gastric cancer immunosuppressive microenvironment heterogeneity: Implications for therapy development. Trends in Cancer, 10(7), 627\u2013642.","journal-title":"Trends in Cancer"},{"issue":"1","key":"10338_CR135","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/s41467-022-29027-8","volume":"13","author":"CD Gatenbee","year":"2022","unstructured":"Gatenbee, C. D., Baker, A. M., Schenck, R. O., Strobl, M., West, J., Neves, M. P., et al. (2022). Immunosuppressive niche engineering at the onset of human colorectal cancer. Nature Communications, 13(1), 1798.","journal-title":"Nature Communications"},{"key":"10338_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.950536","volume":"13","author":"Y Bai","year":"2022","unstructured":"Bai, Y., Chen, D., Cheng, C., Li, Z., Chi, H., Zhang, Y., et al. (2022). Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing. Frontiers in Immunology, 13, Article 950536.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10338_CR137","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01813-y","volume":"22","author":"SK Gautam","year":"2023","unstructured":"Gautam, S. K., Batra, S. K., & Jain, M. (2023). Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma. Molecular Cancer, 22(1), Article 118.","journal-title":"Molecular Cancer"},{"issue":"2","key":"10338_CR138","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1084\/jem.191.2.321","volume":"191","author":"NL Diehl","year":"2000","unstructured":"Diehl, N. L., Enslen, H., Fortner, K. A., Merritt, C., Stetson, N., Charland, C., et al. (2000). Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo. Journal of Experimental Medicine, 191(2), 321\u2013334.","journal-title":"Journal of Experimental Medicine"},{"issue":"12","key":"10338_CR139","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.4049\/jimmunol.156.12.4535","volume":"156","author":"J Sen","year":"1996","unstructured":"Sen, J., Kapeller, R., Fragoso, R., Sen, R., Zon, L. I., & Burakoff, S. J. (1996). Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase. Journal of Immunology, 156(12), 4535\u20134538.","journal-title":"Journal of Immunology"},{"issue":"1","key":"10338_CR140","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1042\/BCJ20200661","volume":"478","author":"MP Damasio","year":"2021","unstructured":"Damasio, M. P., Marchingo, J. M., Spinelli, L., Hukelmann, J. L., Cantrell, D. A., & Howden, A. J. M. (2021). Extracellular signal-regulated kinase (ERK) pathway control of CD8+ T cell differentiation. Biochemical Journal, 478(1), 79\u201398.","journal-title":"Biochemical Journal"},{"key":"10338_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030421","author":"S Rocha","year":"2021","unstructured":"Rocha, S., Basto, A. P., Ijsselsteijn, M. E., Teles, S. P., Azevedo, M. M., Goncalves, G., et al. (2021). Immunophenotype of gastric tumors unveils a pleiotropic role of regulatory T cells in tumor development. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13030421","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10338_CR142","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1053\/j.gastro.2009.06.053","volume":"137","author":"FA Sinicrope","year":"2009","unstructured":"Sinicrope, F. A., Rego, R. L., Ansell, S. M., Knutson, K. L., Foster, N. R., & Sargent, D. J. (2009). Intraepithelial effector (CD3+)\/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology, 137(4), 1270\u20139.","journal-title":"Gastroenterology"},{"issue":"7","key":"10338_CR143","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng, C., Zheng, L., Yoo, J. K., Guo, H., Zhang, Y., Guo, X., et al. (2017). Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell, 169(7), 1342\u201356 e16.","journal-title":"Cell"},{"issue":"3","key":"10338_CR144","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/2159-8290.CD-19-0958","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Lazarus, J., Steele, N. G., Yan, W., Lee, H. J., Nwosu, Z. C., et al. (2020). Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis. Cancer Discovery, 10(3), 422\u201339.","journal-title":"Cancer Discovery"},{"issue":"4","key":"10338_CR145","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1172\/JCI89281","volume":"127","author":"EA Ansa-Addo","year":"2017","unstructured":"Ansa-Addo, E. A., Zhang, Y., Yang, Y., Hussey, G. S., Howley, B. V., Salem, M., et al. (2017). Membrane-organizing protein moesin controls Treg differentiation and anti-tumor immunity via TGF-beta signaling. The Journal of Clinical Investigation, 127(4), 1321\u20131337.","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10338_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021419","volume":"6","author":"JS Zhao","year":"2011","unstructured":"Zhao, J. S., Li, W. J., Ge, D., Zhang, P. J., Li, J. J., Lu, C. L., et al. (2011). Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. PLoS ONE, 6(6), Article e21419.","journal-title":"PLoS ONE"},{"issue":"2","key":"10338_CR147","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1006\/abbi.1994.1199","volume":"310","author":"H Kim","year":"1994","unstructured":"Kim, H., Yang, X. L., Rosada, C., Hamilton, S. R., & August, J. T. (1994). CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Archives of Biochemistry and Biophysics, 310(2), 504\u2013507.","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"1","key":"10338_CR148","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12920-022-01383-w","volume":"15","author":"W Hou","year":"2022","unstructured":"Hou, W., Kong, L., Hou, Z., & Ji, H. (2022). CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer. BMC Medical Genomics, 15(1), 225.","journal-title":"BMC Medical Genomics"},{"issue":"1","key":"10338_CR149","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0168-8278(00)80192-0","volume":"32","author":"K Endo","year":"2000","unstructured":"Endo, K., & Terada, T. (2000). Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. Journal of Hepatology, 32(1), 78\u201384.","journal-title":"Journal of Hepatology"},{"issue":"9","key":"10338_CR150","first-page":"1831","volume":"55","author":"CJ Rall","year":"1995","unstructured":"Rall, C. J., & Rustgi, A. K. (1995). CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Research, 55(9), 1831\u20131835.","journal-title":"Cancer Research"},{"issue":"17","key":"10338_CR151","first-page":"4427","volume":"59","author":"T Fujisaki","year":"1999","unstructured":"Fujisaki, T., Tanaka, Y., Fujii, K., Mine, S., Saito, K., Yamada, S., et al. (1999). CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Research, 59(17), 4427\u20134434.","journal-title":"Cancer Research"},{"issue":"11","key":"10338_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027063","volume":"6","author":"GF Le Bras","year":"2011","unstructured":"Le Bras, G. F., Allison, G. L., Richards, N. F., Ansari, S. S., Washington, M. K., & Andl, C. D. (2011). CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion. PLoS One, 6(11), Article e27063.","journal-title":"PLoS One"},{"issue":"22","key":"10338_CR153","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1158\/1078-0432.CCR-15-3115","volume":"22","author":"S Zhao","year":"2016","unstructured":"Zhao, S., Chen, C., Chang, K., Karnad, A., Jagirdar, J., Kumar, A. P., et al. (2016). CD44 expression level and isoform contributes to pancreatic cancer cell plasticity, invasiveness, and response to therapy. Clinical Cancer Research, 22(22), 5592\u2013604.","journal-title":"Clinical Cancer Research"},{"issue":"16","key":"10338_CR154","first-page":"3719","volume":"58","author":"JA Reeder","year":"1998","unstructured":"Reeder, J. A., Gotley, D. C., Walsh, M. D., Fawcett, J., & Antalis, T. M. (1998). Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Research, 58(16), 3719\u201326.","journal-title":"Cancer Research"},{"issue":"20","key":"10338_CR155","first-page":"4754","volume":"53","author":"VJ Wielenga","year":"1993","unstructured":"Wielenga, V. J., Heider, K. H., Offerhaus, G. J., Adolf, G. R., van den Berg, F. M., Ponta, H., et al. (1993). Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Research, 53(20), 4754\u20134756.","journal-title":"Cancer Research"},{"key":"10338_CR156","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1746-1596-9-79","volume":"9","author":"Z Li","year":"2014","unstructured":"Li, Z., Chen, K., Jiang, P., Zhang, X., Li, X., & Li, Z. (2014). CD44v\/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Diagnostic Pathology, 9, 79.","journal-title":"Diagnostic Pathology"},{"issue":"6","key":"10338_CR157","doi-asserted-by":"publisher","first-page":"939","DOI":"10.21873\/invivo.11017","volume":"30","author":"D Schizas","year":"2016","unstructured":"Schizas, D., Moris, D., Kanavidis, P., Michalinos, A., Sioulas, A., Pavlakis, K., et al. (2016). The prognostic value of CD44 expression in epithelial-mesenchymal transition: Preliminary data from patients with gastric and esophageal cancer. In Vivo, 30(6), 939\u2013944.","journal-title":"In Vivo"},{"issue":"13","key":"10338_CR158","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-12-0299","volume":"72","author":"K Mima","year":"2012","unstructured":"Mima, K., Okabe, H., Ishimoto, T., Hayashi, H., Nakagawa, S., Kuroki, H., et al. (2012). CD44s regulates the TGF-beta-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Research, 72(13), 3414\u20133423.","journal-title":"Cancer Research"},{"key":"10338_CR159","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fonc.2019.00309","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang, Z., Tang, Y., Xie, L., Huang, A., Xue, C., Gu, Z., et al. (2019). The prognostic and clinical value of CD44 in colorectal cancer: A meta-analysis. Frontiers in Oncology, 9, 309.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10338_CR160","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/gut.46.1.14","volume":"46","author":"T Gotoda","year":"2000","unstructured":"Gotoda, T., Matsumura, Y., Kondo, H., Ono, H., Kanamoto, A., Kato, H., et al. (2000). Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut, 46(1), 14\u201319.","journal-title":"Gut"},{"issue":"12","key":"10338_CR161","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1172\/JCI123360","volume":"128","author":"JD Klement","year":"2018","unstructured":"Klement, J. D., Paschall, A. V., Redd, P. S., Ibrahim, M. L., Lu, C., Yang, D., et al. (2018). An osteopontin\/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. The Journal of Clinical Investigation, 128(12), 5549\u20135560.","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10338_CR162","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/omi.2021.0025","volume":"25","author":"K Dzobo","year":"2021","unstructured":"Dzobo, K., & Sinkala, M. (2021). Cancer stem cell marker CD44 plays multiple key roles in human cancers: Immune suppression\/evasion, drug resistance, epithelial-mesenchymal transition, and metastasis. OMICS: A Journal of Integrative Biology, 25(5), 313\u2013332.","journal-title":"OMICS: A Journal of Integrative Biology"},{"issue":"3","key":"10338_CR163","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/0008-5472.CAN-19-1108","volume":"80","author":"T Kong","year":"2020","unstructured":"Kong, T., Ahn, R., Yang, K., Zhu, X., Fu, Z., Morin, G., et al. (2020). CD44 promotes PD-L1 expression and its tumor-intrinsic function in breast and lung cancers. Cancer Research, 80(3), 444\u201357.","journal-title":"Cancer Research"},{"issue":"6","key":"10338_CR164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065821","volume":"8","author":"M Song","year":"2013","unstructured":"Song, M., Chen, D., Lu, B., Wang, C., Zhang, J., Huang, L., et al. (2013). PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer. PLoS ONE, 8(6), Article e65821.","journal-title":"PLoS ONE"},{"issue":"2","key":"10338_CR165","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","volume":"6","author":"W Peng","year":"2016","unstructured":"Peng, W., Chen, J. Q., Liu, C., Malu, S., Creasy, C., Tetzlaff, M. T., et al. (2016). Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discovery, 6(2), 202\u2013216.","journal-title":"Cancer Discovery"},{"issue":"17","key":"10338_CR166","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1158\/0008-5472.CAN-18-0365","volume":"78","author":"TB Shabaneh","year":"2018","unstructured":"Shabaneh, T. B., Molodtsov, A. K., Steinberg, S. M., Zhang, P., Torres, G. M., Mohamed, G. A., et al. (2018). Oncogenic BRAF(V600E) governs regulatory T-cell recruitment during melanoma tumorigenesis. Cancer Research, 78(17), 5038\u201349.","journal-title":"Cancer Research"},{"issue":"279","key":"10338_CR167","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa4691","volume":"7","author":"S Hu-Lieskovan","year":"2015","unstructured":"Hu-Lieskovan, S., Mok, S., Homet Moreno, B., Tsoi, J., Robert, L., Goedert, L., et al. (2015). Improved anti-tumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma. Science Translational Medicine, 7(279), Article 279ra41.","journal-title":"Science Translational Medicine"},{"issue":"9","key":"10338_CR168","doi-asserted-by":"publisher","first-page":"2102620","DOI":"10.1002\/advs.202102620","volume":"9","author":"Y Yin","year":"2022","unstructured":"Yin, Y., Liu, B., Cao, Y., Yao, S., Liu, Y., Jin, G., et al. (2022). Colorectal cancer-derived small extracellular vesicles promote tumor immune evasion by upregulating PD-L1 expression in tumor-associated macrophages. Adv Sci (Weinh)., 9(9), 2102620.","journal-title":"Adv Sci (Weinh)."},{"issue":"7","key":"10338_CR169","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1593\/neo.13706","volume":"15","author":"Q Chang","year":"2013","unstructured":"Chang, Q., Bournazou, E., Sansone, P., Berishaj, M., Gao, S. P., Daly, L., et al. (2013). The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia, 15(7), 848\u2013862.","journal-title":"Neoplasia"},{"issue":"1","key":"10338_CR170","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2005.12.003","volume":"244","author":"F Esfandi","year":"2006","unstructured":"Esfandi, F., Mohammadzadeh Ghobadloo, S., & Basati, G. (2006). Interleukin-6 level in patients with colorectal cancer. Cancer Letters, 244(1), 76\u201378.","journal-title":"Cancer Letters"},{"issue":"4","key":"10338_CR171","first-page":"1171","volume":"40","author":"G Xie","year":"2012","unstructured":"Xie, G., Yao, Q., Liu, Y., Du, S., Liu, A., Guo, Z., et al. (2012). IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures. International Journal of Oncology, 40(4), 1171\u20131179.","journal-title":"International Journal of Oncology"},{"issue":"4","key":"10338_CR172","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson, D. E., O\u2019Keefe, R. A., & Grandis, J. R. (2018). Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nature Reviews. Clinical Oncology, 15(4), 234\u201348.","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"33","key":"10338_CR173","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/onc.2009.180","volume":"28","author":"NJ Sullivan","year":"2009","unstructured":"Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V., Ramirez, N., et al. (2009). Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene, 28(33), 2940\u20132947.","journal-title":"Oncogene"},{"issue":"11","key":"10338_CR174","first-page":"4439","volume":"29","author":"KA Bowen","year":"2009","unstructured":"Bowen, K. A., Doan, H. Q., Zhou, B. P., Wang, Q., Zhou, Y., Rychahou, P. G., et al. (2009). PTEN loss induces epithelial\u2013mesenchymal transition in human colon cancer cells. Anticancer Research, 29(11), 4439\u20134449.","journal-title":"Anticancer Research"},{"issue":"4","key":"10338_CR175","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/carcin\/bgaa128","volume":"42","author":"CH Jiang","year":"2021","unstructured":"Jiang, C. H., Liang, W. H., Li, F. P., Xie, Y. F., Yuan, X., Zhang, H. J., et al. (2021). Distribution and prognostic impact of M1 macrophage on esophageal squamous cell carcinoma. Carcinogenesis, 42(4), 537\u2013545.","journal-title":"Carcinogenesis"},{"issue":"10","key":"10338_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3446","volume":"24","author":"S Yang","year":"2022","unstructured":"Yang, S., Zhao, H., Xiao, W., Shao, L., Zhao, C., & Sun, P. (2022). Extracellular vesicle-packaged miR-181c-5p from epithelial ovarian cancer cells promotes M2 polarization of tumor-associated macrophages via the KAT2B\/HOXA10 axis. Journal of Gene Medicine, 24(10), Article e3446.","journal-title":"Journal of Gene Medicine"},{"issue":"1","key":"10338_CR177","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10637-021-01159-6","volume":"40","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Wang, N., Zhang, Y., Yu, H., & Wu, Q. (2022). KAT2B is an immune infiltration-associated biomarker predicting prognosis and response to immunotherapy in non-small cell lung cancer. Investigational New Drugs, 40(1), 43\u201357.","journal-title":"Investigational New Drugs"},{"issue":"2","key":"10338_CR178","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41419-023-05625-2","volume":"14","author":"J Zhao","year":"2023","unstructured":"Zhao, J., Zhou, X., Chen, B., Lu, M., Wang, G., Elumalai, N., et al. (2023). p53 promotes peroxisomal fatty acid beta-oxidation to repress purine biosynthesis and mediate tumor suppression. Cell Death & Disease, 14(2), 87.","journal-title":"Cell Death & Disease"},{"issue":"6247","key":"10338_CR179","doi-asserted-by":"publisher","DOI":"10.1126\/science.1261669","volume":"349","author":"KW Yoon","year":"2015","unstructured":"Yoon, K. W., Byun, S., Kwon, E., Hwang, S. Y., Chu, K., Hiraki, M., et al. (2015). Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science, 349(6247), Article 1261669.","journal-title":"Science"},{"key":"10338_CR180","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40425-015-0053-5","volume":"3","author":"G Guo","year":"2015","unstructured":"Guo, G., & Cui, Y. (2015). New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy. Journal for Immunotherapy of Cancer, 3, 9.","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"1","key":"10338_CR181","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-024-01578-x","volume":"17","author":"X Chong","year":"2024","unstructured":"Chong, X., Madeti, Y., Cai, J., Li, W., Cong, L., Lu, J., et al. (2024). Recent developments in immunotherapy for gastrointestinal tract cancers. Journal of Hematology & Oncology, 17(1), 65.","journal-title":"Journal of Hematology & Oncology"},{"issue":"1","key":"10338_CR182","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","volume":"17","author":"P Farhangnia","year":"2024","unstructured":"Farhangnia, P., Khorramdelazad, H., Nickho, H., & Delbandi, A. A. (2024). Current and future immunotherapeutic approaches in pancreatic cancer treatment. Journal of Hematology & Oncology, 17(1), 40.","journal-title":"Journal of Hematology & Oncology"},{"issue":"6","key":"10338_CR183","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3748\/wjg.v29.i6.1054","volume":"29","author":"DS Mandlik","year":"2023","unstructured":"Mandlik, D. S., Mandlik, S. K., & Choudhary, H. B. (2023). Immunotherapy for hepatocellular carcinoma: Current status and future perspectives. World Journal of Gastroenterology, 29(6), 1054\u20131075.","journal-title":"World Journal of Gastroenterology"},{"key":"10338_CR184","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003464","author":"SH Chen","year":"2021","unstructured":"Chen, S. H., Dominik, P. K., Stanfield, J., Ding, S., Yang, W., Kurd, N., et al. (2021). Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes anti-tumor immunity. Journal for ImmunoTherapy of Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-003464","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10338_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216735","volume":"587","author":"K Zhao","year":"2024","unstructured":"Zhao, K., Chen, L., Xie, Y., Ren, N., Li, J., Zhai, X., et al. (2024). m6A\/HOXA10-AS\/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1\/Nrf2 pathways. Cancer Letters, 587, Article 216735.","journal-title":"Cancer Letters"},{"issue":"16","key":"10338_CR186","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/sj.gt.3301245","volume":"7","author":"CN Bagot","year":"2000","unstructured":"Bagot, C. N., Troy, P. J., & Taylor, H. S. (2000). Alteration of maternal Hoxa10 expression by in vivo gene transfection affects implantation. Gene Therapy, 7(16), 1378\u201384.","journal-title":"Gene Therapy"},{"key":"10338_CR187","doi-asserted-by":"publisher","first-page":"17057","DOI":"10.1038\/cddiscovery.2017.57","volume":"3","author":"R Jiang","year":"2017","unstructured":"Jiang, R., Ding, L., Zhou, J., Huang, C., Zhang, Q., Jiang, Y., et al. (2017). Enhanced HOXA10 sumoylation inhibits embryo implantation in women with recurrent implantation failure. Cell Death Discov., 3, 17057.","journal-title":"Cell Death Discov."},{"issue":"12","key":"10338_CR188","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1073\/pnas.91.12.5335","volume":"91","author":"A Faiella","year":"1994","unstructured":"Faiella, A., Zappavigna, V., Mavilio, F., & Boncinelli, E. (1994). Inhibition of retinoic acid-induced activation of 3\u2032 human HOXB genes by antisense oligonucleotides affects sequential activation of genes located upstream in the four HOX clusters. Proceedings of the National Academy of Sciences of the United States of America, 91(12), 5335\u20135339.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10338_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00419-1","volume":"4","author":"MC Lauffer","year":"2024","unstructured":"Lauffer, M. C., van Roon-Mom, W., Aartsma-Rus, A., & Collaborative, N. (2024). Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders. Communications Medicine, 4(1), Article 6.","journal-title":"Communications Medicine"},{"issue":"48","key":"10338_CR190","doi-asserted-by":"publisher","first-page":"47792","DOI":"10.1074\/jbc.M305885200","volume":"278","author":"Y Lu","year":"2003","unstructured":"Lu, Y., Goldenberg, I., Bei, L., Andrejic, J., & Eklund, E. A. (2003). HoxA10 represses gene transcription in undifferentiated myeloid cells by interaction with histone deacetylase 2. Journal of Biological Chemistry, 278(48), 47792\u201347802.","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10338_CR191","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/jb\/mvh084","volume":"135","author":"NS Bae","year":"2004","unstructured":"Bae, N. S., Swanson, M. J., Vassilev, A., & Howard, B. H. (2004). Human histone deacetylase SIRT2 interacts with the homeobox transcription factor HOXA10. Journal of Biochemistry, 135(6), 695\u2013700.","journal-title":"Journal of Biochemistry"},{"issue":"4","key":"10338_CR192","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/1541-7786.MCR-17-0655","volume":"16","author":"L Shao","year":"2018","unstructured":"Shao, L., Chen, Z., Peng, D., Soutto, M., Zhu, S., Bates, A., et al. (2018). Methylation of the HOXA10 promoter directs miR-196b-5p-dependent cell proliferation and invasion of gastric cancer cells. Molecular Cancer Research, 16(4), 696\u2013706.","journal-title":"Molecular Cancer Research"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10338-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:24:00Z","timestamp":1778250240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-026-10338-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":192,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["10338"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10338-x","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.K.B. is one of the co-founders of Sanguine Diagnostics and Therapeutics, Inc. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}